Orchestra BioMed Holdings, Inc. ·
OBIO 8-K 2026-10-01
Orchestra BioMed Holdings, Inc. (OBIO) 8-K dated 2026-10-01 — accession 0001104659-26-112586.
Orchestra BioMed Holdings, Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Orchestra BioMed Holdings, Inc. filed a 8-K on 2026-10-01. Accession 0001104659-26-112586.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported OBIO revenue for 2025-12-31 was $33.5M. Net income was -$52.7M. Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. OBIO currently screens at market cap $231.7M.
Not investment advice. The OBIO SEC hub lists recent forms. The stock page is the research view.